Sequana Medical NV (Sequana Medical NV) Total Stockholders Equity : $-3.91 Mil (As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Sequana Medical NV Total Stockholders Equity?

Sequana Medical NV's Total Stockholders Equity for the quarter that ended in Jun. 2023 was $-3.91 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Sequana Medical NV's Book Value per Share for the quarter that ended in Jun. 2023 was $-0.14. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Sequana Medical NV's Debt-to-Equity for the quarter that ended in Jun. 2023 was -4.89.

Sequana Medical NV Total Stockholders Equity Historical Data

The historical data trend for Sequana Medical NV's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sequana Medical NV Total Stockholders Equity Chart

Sequana Medical NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Stockholders Equity

Get a 7-Day Free Trial

-21.34

1.03

0.14

-0.89

-2.28

Sequana Medical NV Quarterly Data
	Dec15	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial									13.16	-0.89	13.73	-2.28	-3.91

Sequana Medical NV (GREY:SQNMF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Sequana Medical NV's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-3.911	-	0)	/	28.1917
	=	-0.14

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Sequana Medical NV's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.426	+	15.69)	/	-3.911
	=	-4.89

Sequana Medical NV Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Sequana Medical NV's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Sequana Medical NV (Sequana Medical NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sequana Medical NV (GREY:SQNMF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

2SE:Germany SEQUA:Belgium

Address

Kortrijksesteenweg 1112 ,bus 102, Sint-Denijs-Westrem, Ghent, BEL, 9051

Website

https://www.sequanamedical.com

Sequana Medical NV is a commercial-stage medical device company focused on the development of treatment solutions for the management of fluid overload in liver disease, malignant ascites, and heart failure. The company's products include an alfa pump, which provides a treatment solution for the long-term management of liver refractory ascites and malignant ascites with safety, efficacy, and quality of life benefits demonstrated in multiple clinical studies and over 750 implants. The company's geographical segments include Switzerland, Germany, the United Kingdom, and the Rest of the world, out of which Germany accounts for the majority of the revenue.

Sequana Medical NV (Sequana Medical NV) Headlines

No Headlines